Benoit spent over 30 years growing healthcare businesses and solving fast growth-related issues as an entrepreneur, advisor and deal maker, or independent board member.
He has an unrivaled experience in pharmaceutical outsourcing. He created and led an advisory firm, a central lab, and a clinical project monitoring unit, the three business units of which became the leading clinical stage CRO in Continental Europe in the late 90s with over 400 people, mainly located in France, Italy, and Germany. He was a board member at Mapi Group, then a late-phase CRO with a few dozen of people, which today is the world leader in late-phase, patient-centered research with 800 people and revenues north of €100m.
Benoit has a dual scientific (PharmD Pharmacy 1984; PhD Pharmaceutical Sciences/Biotechnology 1986) and business (Advanced Management Program Harvard Business School 2002) education. His professional background enabled him to gain an in-depth knowledge of all aspects of a healthcare venture stage company and to favor understanding and collaboration between scientists and business persons.
In the investment banking field, he has been the head of Puilaetco (since acquired by KBC) research team between 1998 and 2002, instrumental in the emergence of a fund investing in innovative healthcare companies and of what became the reference M&A healthcare team in Europe (Bryan Garnier). He sourced and led the execution of over 40 M&A transactions and financing rounds for biotechnology and medical device companies, or CROs. He is an advisor to IMAP, a 400 M&A professional network with a presence in over 40 countries, ranked in the worldwide top 5 Thomson Financials league tables in the small and mid-markets for many years.
With over 30 years of general management and global operations experience, Tim joined the company in March 2019 with a focus on the integration of business operations to ensure efficiency and bring best market practices on board. Tim has worked extensively in laboratory and commercial settings, including Quintiles Transnational and Q2 Solutions, where he served as Global Head for Bioanalytical, Immunoassay, and Absorption, Distribution, Metabolism and Excretion (ADME) laboratories. He was responsible for multiple sites in the US and Europe and was the Head of Central Labs in the Americas with sites in North and South America with over 500 employees. In the COO role, Tim has global responsibility for Laboratory Operations, Project Management, Data Management, Quality Assurance, and Information Technology. He graduated from the University of Massachusetts with a degree in Business Management.
Vahé has 25 years of experience in finance and accounting, with the last 15 years in the Pharma/Vaccine industry, mainly as North American Finance Head for GlaxoSmithKline Vaccines (GSK).
He also worked in the technology industry for private and public companies, for start-up and global structures in the manufacturing and servicing industries. During his career, Vahé was involved in M&A, integrations, IPO, global transactions, but also with operating responsibilities by leading finance teams. In 2015, he was involved in the creation of NEOMED-LABS by leading the project from the GSK side. He joined the company as a CFO in August 2017 where he manages the finance functions and supports the strategic growth of the company. Vahé is a CPA-CMA and holds an MBA from HEC Montreal.
Mounia leads Nexelis’ corporate strategies and development. Prior to joining the company, she was Director, Scientific Affairs at the NEOMED Institute, responsible for the identification and evaluation of new opportunities to complement NEOMED’s prospecting activities.
Before joining the NEOMED initiative, she was Director of Programs at CQDM, where she was responsible for the evaluation and management of research projects and funding programs. Previously, she was Investment Manager at MSBi Valorization, where she covered all aspects of the valorization and investment process, including identification, evaluation, due diligence, negotiation, and fundraising for opportunities in the life sciences sector. She was also actively involved in business development activities with potential industry partners. She started her career as leader of the cellular biology group at Bellus Health (formerly Neurochem Inc.), where she was involved in the development of therapeutics targeting Alzheimer’s disease and diabetes.
Mounia holds a PhD degree in Neuroscience from Université Pierre et Marie Curie (UPMC) in Paris.
Luc leads the scientific operations at Nexelis to support vaccines and biologics throughout the different phases of clinical trials. Luc is a biochemist by training and holds a PhD degree in Microbiology/Immunology from Laval University.
He is armed with over 20 years of experience in several biotech, CRO, and pharmaceutical companies, with an extensive expertise in ligand-binding and functional assay development, qualification and validation.
Saadya has over 25 years of experience in the CRO industry. She filled different positions in different CROs. She began as a laboratory/instrument manager (LCMS/MS) at Phoenix International, then gradually rose through the ranks to Senior Director of Operations at Biotrial Bioanalytical Services (Warnex Inc).
She oversaw the LBA and the LCMS/MS groups and was responsible for the regulatory affairs, headed many FDA, EMA, client and other agency audits. She was also involved in the CRO industry as a member of the GCC group (Global CRO Consortium) where she collaborated on several bioanalytical white papers.
Abigail joined the company in February of 2019 and serves as Site Head and Vice President of Project Management and Operations. In her current position, Abigail manages all laboratory, project management and facilities’ operations at Seattle. Abigail received a Bachelor of Science degree in Microbiology from the University of Kansas in Lawrence, Kansas. Additionally, she received her Cytotechnologist and Specialist in Laboratory Safety Certifications through the American Society for Clinical Pathology (ASCP). Abigail brings over 20 years of Life Sciences experience to her role at Nexelis. Abigail worked at Covance Central Laboratories, spending over 11 years in a variety of roles in project management, leadership and operations, leading the launch of the Vaccines and Novel Immunotherapeutics department in 2015. In 2018, Abigail joined Q2 Laboratory Solutions as Associate Clinical Operations Director, managing and enhancing strategic client relationships throughout the lifecycle of each project and portfolio.
In her current position Tonya manages the IT group responsible for network infrastructure and systems administration as well as the data management group that provides trial data to our sponsors at the Seattle site. She is also the Data Protection Officer (DPO).
Tonya receive a Bachelor of Arts degree in Biological Sciences from Western Washington University and a Bachelor of Science degree in Electrical Engineering from the University of Washington. She began her career as a systems engineer in aerospace research at Boeing Aerospace. This has been followed by over 25 years of experience in the health care industry. She joined National Health Laboratories (later to become LabCorp) as Assistant Manager of Information Systems where she was able to bring together her experience with computer systems/software and her background in biological sciences. She later joined Pacific Biomarkers (now Nexelis) as Information Systems Manager and in her tenure with the company she has had various roles in overseeing IT, data and project management. Throughout, her teams’ focus is ensuring the integrity of the data from receipt of samples thru reporting as well as meeting data deliverables on or ahead of schedule.